Zephex® Exhibits at DDL 27

Zephex®, Mexichem’s leading brand of HFA medical propellants, will be exhibiting at DDL 27 in Edinburgh from 7th – 9th December, offering insight into its recent developmental work and advice on current issues such as legislative changes.

Mexichem has built on an investment program across the Zephex® business, including substantial increases in package and isotank numbers, with developmental research into new propellants to meet the future requirements of pharmaceutical and environmental regulation.

Dr Tim Noakes, Mexichem’s Medical Products Technical Associate will discuss more of this work during his presentation “The Future of Propellants for pMDIs” on 8th December, including how the performance benefits of current products can be maintained.

The Zephex® team will also be on hand to discuss developments in legislation relevant to the medical propellants industry, including the recent Kigali Amendment to the Montreal Protocol and the EU F-Gas Regulation.

Back to News